Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Non-cash Items (2016 - 2020)

Larimar Therapeutics (LRMR) has disclosed Non-cash Items for 4 consecutive years, with $2.7 million as the latest value for Q3 2019.

  • For the quarter ending Q3 2019, Non-cash Items changed N/A year-over-year to $2.7 million, compared with a TTM value of $2.7 million through Sep 2019, changed N/A, and an annual FY2018 reading of $3.1 million, down 3.32% over the prior year.
  • Non-cash Items was $2.7 million for Q3 2019 at Larimar Therapeutics, down from $3.1 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $3.3 million in Q4 2017 and bottomed at $1.0 million in Q4 2016.
  • Average Non-cash Items over 4 years is $2.5 million, with a median of $2.9 million recorded in 2018.
  • The sharpest move saw Non-cash Items surged 213.2% in 2017, then dropped 3.32% in 2018.
  • Year by year, Non-cash Items stood at $1.0 million in 2016, then soared by 213.2% to $3.3 million in 2017, then decreased by 3.32% to $3.1 million in 2018, then decreased by 14.04% to $2.7 million in 2019.
  • Business Quant data shows Non-cash Items for LRMR at $2.7 million in Q3 2019, $3.1 million in Q4 2018, and $3.3 million in Q4 2017.